Press Releases

Date Title and Summary Additional Formats
Toggle Summary ArQule Summarizes Abstracts Presented At AACR
Pre-clinical findings support c-Met inhibition and activation of DNA damage response mechanisms as novel approaches to treating cancer
View HTML
Toggle Summary ArQule to Present at CIBC Annual Biotechnology & Specialty Pharmaceuticals Conference on April 11, 2007
Live webcast scheduled for 12:45 p.m. eastern time
View HTML
Toggle Summary ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met Inhibitor, for Oral Presentation at ASCO
Additional abstracts related to ArQule products and scientific platforms accepted at ASCO and AACR
View HTML
Toggle Summary ArQule to Present at BIO CEO & Investor Conference 2007 on February 14, 2007
Live Webcast Scheduled for 1:30 P.M. Eastern Time
View HTML
Toggle Summary ArQule Reports Fiscal 2006 Year End and Fourth Quarter Results
Conference call scheduled today at 9:00 a.m. eastern time
View HTML
Toggle Summary ArQule, Inc. to Report Fiscal 2006 Financial Results on February 8, 2007
Conference call and Webcast scheduled for 9:00 a.m. Eastern Time
View HTML
Toggle Summary ArQule Announces $5.0 Million Sponsored Research Agreement with Boston Biomedical, Inc.
Dr. Chiang Li, ArQule's Former Chief Scientific Officer, To Lead New Company
View HTML
Toggle Summary ArQule Announces New Board Member, Michael D. Loberg
ArQule Announces New Board Member, Michael D. Loberg WOBURN, Mass.--(BUSINESS WIRE)--Jan. 17, 2007--ArQule, Inc. (Nasdaq: ARQL) today announced that Michael D. Loberg, Ph.D., has been named to its board of directors. Dr. Loberg brings 27 years of senior management and drug development experience to
View HTML
Toggle Summary ArQule Provides Clinical Trial Update
ArQule Provides Clinical Trial Update WOBURN, Mass.--(BUSINESS WIRE)--Jan. 16, 2007--ArQule, Inc. (NASDAQ: ARQL) today provided an update on its clinical trials with three compounds: ARQ 197, a proprietary, orally administered small molecule inhibitor of the c-Met receptor tyrosine kinase; ARQ 501,
View HTML

Questions or Concerns?

Please feel free to contact by one of the methods below

Online Form   Call (781) 994-0300

These archived presentations and related materials are provided for reference by ArQule, Inc. Information contained in the materials was current only as of the date of the event. ArQule, Inc. does not update or delete outdated information contained in these materials, and it expressly disclaims any obligation to do so. The materials are property of ArQule, Inc. and any use, dissemination or republication of the files is prohibited without the express written consent of ArQule, Inc.